IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 320 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $5,518,000 | -18.3% | 164,503 | -2.9% | 0.69% | -21.8% |
| Q2 2021 | $6,756,000 | -8.3% | 169,365 | +3.3% | 0.88% | +52.4% |
| Q1 2021 | $7,370,000 | -13.7% | 163,923 | +8.6% | 0.58% | -18.1% |
| Q4 2020 | $8,537,000 | +38.2% | 150,995 | +16.0% | 0.71% | +23.8% |
| Q3 2020 | $6,178,000 | -5.3% | 130,199 | +17.6% | 0.57% | -14.4% |
| Q2 2020 | $6,526,000 | +22.9% | 110,678 | -1.4% | 0.67% | +6.2% |
| Q1 2020 | $5,308,000 | -24.1% | 112,262 | -3.0% | 0.63% | -4.8% |
| Q4 2019 | $6,993,000 | -0.2% | 115,763 | -1.1% | 0.66% | -9.5% |
| Q3 2019 | $7,010,000 | -3.3% | 117,009 | +3.7% | 0.73% | -9.9% |
| Q2 2019 | $7,250,000 | -21.4% | 112,808 | -0.7% | 0.81% | -28.3% |
| Q1 2019 | $9,220,000 | +49.3% | 113,593 | -0.6% | 1.13% | +26.0% |
| Q4 2018 | $6,177,000 | +2.0% | 114,266 | -2.7% | 0.90% | +7.0% |
| Q3 2018 | $6,057,000 | +23.0% | 117,434 | -0.6% | 0.84% | +10.3% |
| Q2 2018 | $4,923,000 | -99.9% | 118,152 | -0.4% | 0.76% | -8.8% |
| Q1 2018 | $5,230,180,000 | -12.7% | 118,652 | -0.4% | 0.83% | -13.7% |
| Q4 2017 | $5,991,384,000 | +0.1% | 119,113 | +0.9% | 0.96% | -7.2% |
| Q3 2017 | $5,986,605,000 | -1.8% | 118,079 | -1.5% | 1.04% | -9.7% |
| Q2 2017 | $6,097,176,000 | +26.7% | 119,858 | +0.1% | 1.15% | +23.1% |
| Q1 2017 | $4,812,623,000 | -17.3% | 119,717 | -1.6% | 0.94% | -22.3% |
| Q4 2016 | $5,821,054,000 | +27.3% | 121,703 | -2.5% | 1.20% | +25.6% |
| Q3 2016 | $4,573,148,000 | +58.9% | 124,813 | +1.0% | 0.96% | +44.9% |
| Q2 2016 | $2,877,899,000 | -45.7% | 123,568 | +0.5% | 0.66% | -48.1% |
| Q1 2016 | $5,295,523,000 | +67358.9% | 122,923 | -3.0% | 1.27% | -37.7% |
| Q4 2015 | $7,850,000 | – | 126,763 | – | 2.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |